Key Clinical Message:
A second wave of dyspnea and desaturation is being observed post COVID-19 pneumonia and ARDS. It may be secondary to an ongoing lung inflammation or fibrosis after COVID-19 infection. Steroids may have a role in the management of the inflammation.